What do we know about chronic kidney disease in India: first report of the Indian CKD registry by Rajapurkar, Mohan M et al.
RESEARCH ARTICLE Open Access
What do we know about chronic kidney disease
in India: first report of the Indian CKD registry
Mohan M Rajapurkar
1, George T John
2, Ashok L Kirpalani
3, Georgi Abraham
4, Sanjay K Agarwal
5, Alan F Almeida
6,
Sishir Gang
1, Amit Gupta
7, Gopesh Modi
8, Dilip Pahari
9, Ramdas Pisharody
10, Jai Prakash
11, Anuradha Raman
12,
Devinder S Rana
13, Raj K Sharma
7, RN Sahoo
14, Vinay Sakhuja
15, Ravi Raju Tatapudi
16 and Vivekanand Jha
15*
Abstract
Background: There are no national data on the magnitude and pattern of chronic kidney disease (CKD) in India.
The Indian CKD Registry documents the demographics, etiological spectrum, practice patterns, variations and
special characteristics.
Methods: Data was collected for this cross-sectional study in a standardized format according to predetermined
criteria. Of the 52,273 adult patients, 35.5%, 27.9%, 25.6% and 11% patients came from South, North, West and East
zones respectively.
Results: The mean age was 50.1 ± 14.6 years, with M:F ratio of 70:30. Patients from North Zone were younger and
those from the East Zone older. Diabetic nephropathy was the commonest cause (31%), followed by CKD of
undetermined etiology (16%), chronic glomerulonephritis (14%) and hypertensive nephrosclerosis (13%). About 48%
cases presented in Stage V; they were younger than those in Stages III-IV. Diabetic nephropathy patients were
older, more likely to present in earlier stages of CKD and had a higher frequency of males; whereas those with
CKD of unexplained etiology were younger, had more females and more frequently presented in Stage V. Patients
in lower income groups had more advanced CKD at presentation. Patients presenting to public sector hospitals
were poorer, younger, and more frequently had CKD of unknown etiology.
Conclusions: This report confirms the emergence of diabetic nephropathy as the pre-eminent cause in India.
Patients with CKD of unknown etiology are younger, poorer and more likely to present with advanced CKD. There
were some geographic variations.
Background
The overall magnitude and pattern of chronic kidney
disease (CKD) in India has been studied sporadically
[1-5]. There are no national or regional reports on inci-
d e n c eo rp r e v a l e n c eo fe i t h e rC K Do re n d - s t a g er e n a l
disease (ESRD). In a population based survey of approxi-
mately 570,000 individuals in the Central Indian city of
Bhopal, the crude and age-adjusted ESRD incidence
rates were determined at 151 and 232 pmp, respectively
[6,7]. Studies on prevalence of CKD suffer from the use
of divergent methodologies. In a survey of about 4,000
healthy adults, the prevalence of microalbuminuria and
reduced glomerular filtration rate was 10% and 13%
respectively [8]. In another study [9], 2.5% of 5300 sub-
jects had dipstick positive proteinuria and 4.8% had GFR
< 60 ml/min. Agarwal et al [10] found low GFR (defined
as serum creatinine > 1.8 mg/dl) in 0.8% of 4972 sub-
jects surveyed in Delhi. These data stand in contrast to
data from the developed world, where large population-
based surveys such as the NHANES have shown the
prevalence of CKD to be about 12-20% [11-13].
The contribution of kidney diseases to death in India is
not known. Deaths are registered as a part of medical
certification of cause of death in urban hospitals and sur-
vey of cause of death in the rural areas. The latter was
merged with the Sample Registration System in 1999
[14]. Validated nationally representative estimates of
cause specific mortality, however, are not available [15].
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designated officials (lay reporters and medical attendants
in rural and urban areas respectively) to the Vital Statis-
tics Division of the State Department of Health for
onwards transmission to the Registrar General of India.
Performance analysis studies have pointed out several
flaws, e.g. poor coverage, high incidence of unclassifiable
deaths, long delays and lack of systematic screening [16].
About 80% of all deaths occur at home; the underlying
cause of the terminal illness is often not known. The
listed underlying cause of a death from disease is inaccu-
rate, misclassified or missing for about 50% of deaths
[17]. Verbal autopsy studies conducted by trained per-
sonnel significantly reduced the proportion of deaths due
to unclassifiable causes [17,18]. In a nation-wide verbal
autopsy study conducted by the Indian Council of Medi-
cal Research in 24 districts across 5 states, about 14000
deaths were screened. Noncommunicable diseases were
found to account for 42% of all deaths; genitourinary dis-
eases were listed as the cause in 4.9% of deaths [19].
Broad-based systematic effort has not been made to
collect clinical or epidemiologic data of the CKD popu-
lation. In a country with over 1.2 billion people, a num-
ber of ethnicities, widely divergent socio-economic
strata, rural-urban divide, different food habits and vary-
ing pattern of infections, the spectrum of CKD may not
be uniform in terms of etiologies, patient demographics
and clinical presentation. Lack of access to healthcare
services, especially in the rural areas prevents diagnosis
of CKD.
The Indian CKD Registry was set up by the Indian
Society of Nephrology in 2005 with the aim to serve as a
comprehensive nationwide data warehouse for studying
various aspects of CKD. It was considered that such an
effort would be of value not only for characterization and
documentation of the disease and practice patterns, but
also for identifying special characteristics in any geo-
graphic or demographic group(s), so that tailored preven-
tion or management strategies that appropriately target
these groups can be developed.
The present communication is the first report of the
Registry highlighting the demographics of Indian CKD
patients, the etiological spectrum and comparison
between different geographic zones and across the prac-
tice spectrum of the country.
Methods
The CKD workgroup was initially comprised of 12
nephrologists representing major centers from all parts
of the country, both from the public and private sectors.
In order to ensure uniformity in diagnostic criteria, a set
of definitions for variousc a u s e so fC K Dw a sa d o p t e d
(Additional File 1). Contributors were advised to submit
data for all incident patients after the initial evaluation
was completed so as to allow classification into appropri-
ate diagnostic categories.
A standardized format was developed for data collec-
tion in this cross-sectional study. Fields were designed in
such a way to capture demographic information that
could be used to verify data duplication, since it is not
uncommon for patients to move from one hospital to
another. Guidelines for entering data was also widely cir-
culated and published on registry website. Information
about the socio-economic status and reimbursement
situation was collected. Patients were classified into three
arbitrarily defined income categories to represent low,
middle and upper income groups.
In the initial stages, the data collected included etiology
of CKD, anthropometric data, serum creatinine, presence
of diabetes, hypertension and cardiovascular disease, his-
tory of indigenous medication use and management
details at the time of reporting. Over the subsequent
years, the data form went through three revisions, each
time more data fields were added in order to capture
additional information, such as other laboratory abnorm-
alities, and greater details of drug therapy.
The Registry office was located at MPSRN with MR as
its custodian after obtaining approval from the Institute
Ethics Committee. Data was collected by three methods.
Paper forms in which individual patient data could be
entered were mailed to the Registry office at regular
intervals. Direct entry was possible by online submission
through the Indian CKD Registry website http://ckdri.
org. Places with unreliable internet connectivity could
enter data on a standalone electronic database and
uploaded later to the central server via a weblink.
At the office, the data was verified by an experienced
statistician who picked out obvious errors and removed
duplications. In case data was ambiguous, clarifications
were sought from the submitting center and unsatisfac-
tory submissions were removed. Estimated glomerular fil-
tration was calculated using abbreviated MDRD formula
for the purpose of classifying the patients into different
stages of CKD.
Information about the Registry was disseminated to the
membership of the Indian Society of Nephrology through
mailers and by presentatio n si nm e e t i n g sa c r o s st h e
country. Active efforts were made to contact centers
from all over the country to ensure uniform representa-
tion of all geographic regions. In the first 2 years, the
data collection was limited to adult patients. Later, the
scope was extended to include paediatric cases, and a
separate data collection form was designed in consulta-
tion with Pediatric Nephrologists.
The number of contributing centers rose from 10 to
188 (Additional File 2). For the purpose of regional com-
parisons, the states were grouped into four zones (East,
West, South and North). The zones broadly represent
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and industrialization and people of different ethnicities.
Data is presented as mean ± SD, and was analyzed
using Medcalc 11 (Medcalc, Ghent, Belgium). Continu-
ous data was compared using T test or Mann Whitney
U test. Categorical data was compared using appropriate
contingency tables and chi-square test.
Results
At the end of September 2010, the Registry had received
54,813 submissions, out of which 1818 were pediatric
cases. After weeding out 722 duplicate and incomplete
entries, data on 52,273 adult patients was analyzed. The
contributing centers are distributed in all 4 zones of the
country. Table 1 shows the year-wise breakup of contri-
butions from centers in different zones.
Table 2 shows the demographic data, socioeconomic
profile and etiologies of CKD from different zones. The
overall age was 50.1 ± 14.6 years, and 36,745 (70.3%) of
the subjects were males. Overall, females with CKD
were two and half years younger than males (50.9 ±
14.6 v 48.3 ± 14.4 years). Comparison of data from dif-
ferent zones showed small, but statistically significant
differences in age distribution and sex ratio. Patients
from the North zone were younger and those from the
east zone older compared to those from the south and
west zones.
Diabetic nephropathy was the commonest cause of
CKD in all geographic areas. The second most frequent
cause was CKD of undetermined etiology followed in
almost equal frequency by chronic glomerulonephritis
and hypertensive nephrosclerosis. Zone-wise breakup
showed some geographic differences. CKD of undeter-
mined etiology was encountered most frequent in the
southern part of the country (20.2%) but in the East
Zone, it was reported in only 10%. Diabetic nephropathy
was reported less frequently from the West Zone.
Chronic glomerulonephritis was the cause of CKD in
15.3% of cases from the East Zone and only 12.4% from
the South Zone (p < 0.001). The diagnosis was confirmed
by kidney biopsy in 770 (2%) cases.
Year-wise analysis of the data shows that the etiological
pattern and patient demographics has remained consistent
over the period of data acquisition (Additional File 3).
About 48% of cases were in stage V at presentation, with
the remaining in decreasing order of frequency in lower
stages (Figure 1). This proportion was largely uniform
throughout the country, except in the North Zone, where
stages I-III formed a larger proportion. The mean age of
patients increased progressively from Stage I-IV, but stage
V patients were younger than stages III and IV (Additional
file 4).
Comparison between etiologic groups (Table 3) showed
that patients with diabetic nephropathy were significantly
older (p < 0.0001) and had more males (p < 0.001),
whereas those with undetermined etiology were the
youngest (p < 0.001) and had a greater proportion of
females (p = 0.003). A significantly greater proportion
(50%) of those with CKD of undetermined etiology were
in Stage V (p < 0.001), whereas those with diabetic
nephropathy were more likely to be in earlier (I-IV) stages
(p < 0.0001). Even after excluding all cases with diabetic
nephropathy, those with undetermined etiology were
more likely to present in Stage V (p = 0.003).
A total of 21,469 (42.7%) patients reported a monthly
family income of less than Rs 5000, 44.4% Rs 5-20,000 and
12.9% had income of over Rs 20,000. Patients in the lowest
income group were significantly younger compared to
those with the other two income categories (p < 0.0001).
(Additional file 5). The proportion of patients who were in
stage V, and those with undetermined CKD were signifi-
cantly lower in the highest income group category,
whereas diabetic nephropathy was encountered more fre-
quently in this group (Additional File 6, p < 0.0001).
We compared the profile of patients presenting to public
sector hospitals and private hospitals and noted some
important differences (Table 4). Patients from the poorest
socioeconomic category were seen more frequently in
public sector hospitals. Public sector hospital patients
were significantly younger (p < 0.0001) and presented for
the first time more frequently in stage V CKD (p <
0.0001). In terms of diagnostic categories, patients with
C K Do fu n d e t e r m i n e de t i o l o g ym o r el i k e l yt ob es e e ni n
public sector hospitals whereas hypertensive nephrosclero-
sis was more frequently encountered in private hospitals
(p < 0.0001). Importantly, the proportion of patients with
diabetic nephropathy was similar.
Of all the stage V CKD cases, a majority (61%) were
not on any form of RRT at the time of reporting, 32%
on hemodialysis, 5% on peritoneal dialysis and 2% were
being worked up for transplantation.
Discussion
Over the last decade, CKD has been recognized as a
major global public health problem [20]. Data from
Table 1 The number of cases reported from each zone in
the different years
Year East North South West Total
2006 974 (7.5) 4,491 (34.5) 3,480 (26.7) 4,071 (31.3) 13,231
2007 1,073 (9.7) 2,576 (23.3) 4,052 (36.7) 3,336 (30.2) 11,196
2008 1,523 (13.1) 4,277 (36.7) 3,358 (28.8) 2,486 (21.4) 11,644
2009 687 (6.7) 2,262 (22.2) 4,796 (47.1) 2,443 (24.0) 10,188
2010* 1,511 (23.7) 982 (15.4) 2,869 (44.9) 1,026 (16.1) 6,388
Total 5,768 (11.0) 14,588 (27.9) 18,555 (35.5) 13,362 (25.6) 52,273
Figures in parentheses are percentages
*Till Sep 30, 2010
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bution of CKD towards the development of CVD and
mortality [21]. Moreover, CKD management consumes a
disproportionately large fraction of the available health-
care resources [22].
Registries provide information about incidence, preva-
lence, demographic data, etiologic patterns, comorbidities
and outcomes, and help generate trends that permit iden-
tification of priority areas and long term planning. In
some countries, ESRD treatment funding is linked to sub-
mission of data to the registries whereas the contribution
is voluntary in others. In view of the growing importance
of lower stages of CKD, setting up of CKD Registries has
also been advocated [23].
India does not have established program to manage
CKD patients or even to collect data [24]. Healthcare
delivery takes place through both public and private sys-
tems [1]. Subsidized public sector healthcare is provided
though the primary health centers, block and district level
hospitals, and referral (university) hospitals. Care for
kidney disease is available only at the higher-level hospi-
tals. There is no formal referral system; patients can go to
any hospital, including to referral hospitals anywhere in
the country. A shortage in the number of publicly funded
specialized hospitals forces patients to seek care in expen-
sive private hospitals. A vast majority do not have access
to health insurance, and hence have to fund treatment
from their own resources [25]. Lack of any government
support to dialysis has prevented the development of
ESRD registry in India.
This report is the result of a comprehensive effort to
understand the pattern of CKD across the entire range of
healthcare delivery system, and presents the first compre-
hensive pan-Indian account of CKD. This voluntary effort
was successful, as attested by regular contribution of data
from an increasing number of centers across the country.
The registry confirms diabetic nephropathy as the pre-
eminent cause of CKD in India [6]. Until a couple of dec-
ades ago, the primacy of diabetes as the main cause of
CKD was restricted to private Institutions that were
Table 2 Patient demographics, socioeconomic status, and CKD etiology and severity in different geographic zones
East North South West Total
Number of cases 5,768 14,588 18,555 13,362 52,273
Age (Years) 51.8 ± 14.9 49.1 ± 15.0 50.3 ± 14.0 50.2 ± 14.9 50.1 ± 14.6
Number of females 1,690
(29.3)
4,610
(31.6)
5,073
(27.3)
4,155
(31.1)
15,528
(29.7)
Monthly family Income (n = 50,250)
< Rs 5,000 1,968
(35.2)
6,198
(44.0)
7,873
(44.4)
5,430
(42.3)
21,469
(42.7)
Rs 5,001-20,000 2,471
(44.3)
6,367
(45.2)
7,597
(42.9)
5,866
(45.7)
22,301
(44.4)
> Rs 20,000 1,144
(20.5)
1,530
(10.9)
2,259
(12.7)
1,547
(12.0)
6,480
(12.9)
Causes of CKD
Diabetic nephropathy 1,804
(31.3)
4,554
(31.2)
6,110
(32.9)
3,903
(29.2)
16,371
(31.3)
Undetermined 574
(10.0)
1,967
(13.5)
3,751
(20.2)
2,093
(15.7)
8,385
(16.0)
Chronic glomerulonephritis 885
(15.3)
2,133
(14.6)
2,302
(12.4)
1,897
(14.2)
7,217
(13.8)
Hypertensive nephrosclerosis 840
(14.6)
1782
(12.2)
2,190
(11.8)
1,929
(14.4)
6,741
(12.9)
Chronic interstitial nephritis 476
(8.3)
1,085
(7.4)
1,177
(6.3)
943
(7.1)
3,681
(7.0)
Obstructive uropathy 201
(3.5)
537
(3.7)
505
(2.7)
533
(4.0)
1,776
(3.4)
ADPKD 116
(2.0)
499
(3.4)
367
(2.0)
384
(2.9)
1,366
(2.6)
Miscellaneous 808
(14.0)
1,846
(12.7)
1,996
(10.8)
1,489
(11.1)
6,139
(11.7)
Renovascular disease 56
(1.0)
121
(0.8)
108
(0.6)
146
(1.1)
431
(0.8)
Graft failure 8
(0.1)
64
(0.4)
49
(0.3)
45
(0.3)
166
(0.3)
CKD: chronic kidney disease, ADPKD: autosomal dominant polycystic kidney disease
Figures in parentheses are percentages
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[2]. Currently, however, diabetic kidney disease is recog-
nized as the most frequent cause of CKD across the coun-
try. This has paralleled the emergence of India as the
diabetes capital of the world [26]. With increasing urbani-
zation, the number of diabetics is likely to rise, and an
increase in the number of patients with kidney disease is
to be expected. This is a call to action for professional
societies, public health professionals and policy-makers to
develop strategies to deal with this issue at an early stage.
The other important finding is the identification of CKD
of undetermined etiology as the cause in as many as 16%
of all CKD subjects. In older reports [2,3,5], this diagnostic
category was not recognized. Patients in this category pre-
sented more frequently with advanced CKD, relatively
short history, few symptoms until late in the disease,
absent or mild hypertension and little or no proteinuria.
There was no geographic pattern in this diagnosis. It can
be postulated that delayed presentation due to limited
access to healthcare makes establishing the primary diag-
nosis difficult. Unique risk factors in the Indian population
must be considered, however. These include dietary habits,
use of indigenous medicines and possibility of industrial
contamination. A significant proportion of population in
this region consumes a variety of herbs and fruits.
Whether any of these have an adverse impact on kidney
function remains unknown. An association of CKD with
herbal medicines has already been established in some
parts of the world [27,28].
CKD of uncertain etiology has also been reported
from other parts of South Asia and amongst South
Asians living in UK [29]. In Sri Lanka, male paddy farm-
ers of poor socioeconomic status present with progres-
sive non-proteinuric renal failure [30]. Suggested
Figure 1 Shows the breakup of patients presenting at different CKD stages in different zones of the country.
Table 3 Comparison of age, gender distribution and CKD stages in different etiologies of CKD
Etiology of CKD Age (years) Gender ratio (M:F) CKD Stages
1 2 3 4 5 Total
Diabetic nephropathy 52.3 ± 14.2 2.8:1 263
(1.7)
647
(4.2)
3,012
(20.2)
4,177
(27.2)
7,257
(47.3)
15,356
Undetermined 47.4 ± 14.7 2.2:1 154
(1.9)
320
(4)
1,515
(19)
2,003
(25.1)
3,982
(49.9)
7,974
All others 49.6 ± 14.8 2.3:1 588
(2.3)
1,170
(4.6)
5,087
(19.8)
6,505
(25.3)
12,324
(48)
25,674
CKD: chronic kidney disease
Figures in parentheses are percentages
Rajapurkar et al. BMC Nephrology 2012, 13:10
http://www.biomedcentral.com/1471-2369/13/10
Page 5 of 8etiologies include environmental toxins such as residual
pesticides, fluoride, aluminum, cadmium and cyanobac-
teria in drinking water. Such observations argue against
the assumption that CKD is primarily because of wester-
nization and more likely to be encountered in the afflu-
ent urban population. Maternal malnutrition and
resultant low birth weight in the offspring might predis-
pose to CKD, possibly due to low nephron numbers.
This finding presents a challenge for developers of
CKD detection programs, as these patients do not exhi-
bit the usual parameters that define high risk for CKD
such as hypertension or diabetes and do not demon-
strate proteinuria.
The report highlights difference in the CKD popula-
tion presenting to private or public sector hospitals. The
CKD population in the public sector hospitals was com-
prised of a higher proportion of younger patients from
poorer socioeconomic classes presenting in stages V
CKD of uncertain etiology. There was no difference in
the proportion of diabetic kidney disease, contrary to
that noted in some of the earlier reports [2,3,5].
Over 60% of Stage V CKD patients were being mana-
ged with conservative treatment without dialysis at the
time of presentation. Previous studies have shown that a
large proportion of these cases require emergency dialysis
soon after presentation but are unable to continue it on a
long-term basis because of financial reasons [31,32].
Moreover, late presentation results in catastrophic “out
of pocket” expenditure [32], pushing many already poor
families into abject poverty [33]. This is an important
issue for the Indian healthcare administrators. Should a
developing country like India, with a high burden of
infectious diseases, deficiency disorders and other public
health challenges, offer universal renal replacement ther-
apy (RRT)? A number of countries with comparable
stage of economic development in South America and
East Asia already do so. Even in India, some states have
started programs to provide either highly subsidized or
free RRT to its citizens [34,35]. However, data suggest
that the implementation of such programs is incomplete,
and a large majority even in these states still are not yet
covered. The Government of India is currently consider-
ing providing dialysis to the entire population through a
network of standalone centers through partnership with
private healthcare providers [24]. There is, however, a
shortage of trained dialysis physicians, technicians and
nurses, for which training program are being devised.
The strengths of this report are its pan-Indian nature,
the large number of participating centers from private and
public sector healthcare facilities (including all the major
medical Institutions of the country), use of uniform diag-
nostic labels, the large patient numbers and the consis-
tency of data. An important reason for differences in the
earlier reports could have been variable interpretation of
clinical data for application of diagnostic labels. Adoption
of a set of diagnostic criteria for making etiologic diagnosis
by the registry participants was an important initial step in
the current exercise. As there in no formal system of refer-
rals or reimbursement, a majority of patients go from hos-
pital to hospital in search of the most cost-effective
treatment; hence appropriate measures were taken to
ensure identification and removal of duplicate data. So far
as representation of Stage V CKD is concerned, the report
included cases irrespective of whether they received dialy-
sis, which is different from ESRD registries elsewhere,
which provide an account only treated cases.
This report has limitations too. Since the data has been
contributed only by nephrologists, patients with more
advanced stages of CKD are over-represented. It is not
possible to calculate the incidence or prevalence of CKD
from the registry because the data is hospital-based. Con-
tribution to the registry was voluntary and despite stren-
uous efforts, the reach does not cover every nephrologist
or even every patient from all participating centers. The-
oretically, it can be said that as all stage V CKD patients
Table 4 Patient demographics, socioeconomic status, and
CKD etiology and severity in according to presentation
in public or private hospitals
Private Public Total
Number of cases 26,290 25,983 52,273
Age (Years) 52.0 ± 14.7 48.2 ± 14.3 50.1 ± 14.6
Number of females 8,068 (30.7) 7,460 (28.8) 15,528 (29.7)
Monthly family Income 25,302 24,948 50,250
< Rs 5,000 9,190 (36.3) 12,279 (49.2) 21,469 (42.7)
Rs 5,001-20,000 12,305 (48.6) 9,996 (40) 22,301 (44.4)
> Rs 20,000 3,807 (15) 2,673 (10.7) 6480 (12.9)
Causes of CKD
Diabetic nephropathy 8,378 (31.9) 7,993 (30.8) 16,371 (31.3)
Undetermined 3,692 (14.0) 4,693 (18.1) 8,385 (16.0)
Chronic glomerulonephritis 3,562 (13.5) 3,655 (14.1) 7,217 (13.8)
Hypertensive nephrosclerosis 3,799 (14.5) 2,942 (11.3) 6,741 (12.9)
Chronic interstitial nephritis 1,811 (6.9) 1,870 (7.2) 3,681 (7.0)
Obstructive uropathy 941 (3.6) 835 (3.2) 1,776 (3.4)
ADPKD 747 (2.8) 619 (2.4) 1,366 (2.6)
Miscellaneous 3052 (11.6) 3087 (11.9) 6,139 (11.7)
Renovascular disease 222 (0.8) 209 (0.8) 431 (0.8)
Graft failure 86 (0.3) 80 (0.3) 166 (0.3)
CKD stages (n = 49,004)
I 464 (1.9) 541 (2.2) 1,005 (2.1)
II 1,163 (4.8) 974 (3.9) 2,137 (4.4)
III 5,455 (22.4) 4,159 (16.8) 9,614 (19.6)
IV 6,591 (27.1) 3,091 (24.7) 12,685 (25.9)
V 10,644 (43.8) 12,919 (52.3) 23,563 (48.1)
CKD: chronic kidney disease, ADPKD: autosomal dominant polycystic kidney
disease
Figures in parentheses are percentages
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possible to get the ESRD incidence and/or prevalence if
data from all nephrologists in a region were to become
available. Such a strategy allowed calculation of ESRD
incidence in the city of Bhopal where one hospital served
a defined population [6]. However, experience suggests
that a significant number of cases, especially from the
underprivileged sections of the society do not reach the
attention of a nephrologist and hence these figures will
likely underestimate incidence and/or prevalence data.
This is a cross-sectional analysis, and it is possible that
some of the patients with advanced CKD who were on
conservative therapy without dialysis could have been
initiated on RRT at a later date.
Overall, the findings show that despite some variations,
the demographic pattern and etiologic break-up of CKD
is largely uniform throughout the country. This is impor-
tant, as it would support the development of a coherent
national strategy to deal with CKD as a nation-wide pub-
lic health problem. One of the major challenges is ensure
that more cases come to attention in the earlier stages of
CKD through institution of CKD detection initiatives so
that appropriate preventive steps can be undertaken, and
to provide optimal care to a larger proportion of those
who reach advanced CKD stages.
More research is needed to understand specific issues,
such as specific differences between CKD in rural and
urban dwellers and risk factor analysis in those with
unexplained CKD. More detailed in-depth analysis will
permit better understanding of factors such as age, eth-
nicity, level of development and poverty in different
regions on CKD burden, causes and management. It
would also be useful to concentrate on areas with good
penetration of the registry, as this will allow a clearer
understanding of the disease burden, more information
on longitudinal course of patients which will permit bet-
ter risk factor and outcome analysis.
Conclusions
This report confirms the emergence of diabetic nephro-
pathy as the pre-eminent cause of CKD in India. A sig-
nificant proportion has CKD of undertermined etiology.
These patients are younger, have a lower income and
more advanced CKD. Patients presenting to public sec-
t o rh o s p i t a l sa r ep o o r e r ,y o u n g e r ,a n dm o r el i k e l yt o
have CKD of unknown etiology. There are minor geo-
graphic variations in the disease pattern.
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